2015
DOI: 10.2147/ott.s91696
|View full text |Cite
|
Sign up to set email alerts
|

miR-122 inhibits metastasis and epithelial–mesenchymal transition of non-small-cell lung cancer cells

Abstract: miR-122 may function as a novel tumor suppressor. Expression of miR-122 could suppress the proliferation of multi-kinds of human cancer cell lines. In this work, expression of miR-122 via adenoviral vector in non-small-cell lung cancer (NSCLC) cells reduces the number of invasion and migration cells. miR-122 attenuates the epithelial–mesenchymal transition process, which mediates cancer cells metastasis in NSCLC cells A549 and H460. The mechanisms data reveals that miR-122 would disrupt the epithelial–mesenchy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
16
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(17 citation statements)
references
References 27 publications
(42 reference statements)
1
16
0
Order By: Relevance
“…27 In NSCLC, the expression of miR-221 and miR-10a were up-regulated, and their overexpression could accelerate the proliferation, migration and invasion of cancer cells. 28,29 Consistent with previous reports, 16,17 we confirmed that miR-122-5p was down-regulated in NSCLC tissues and involved in the progression of NSCLC as a tumor suppressor. In addition, we also found that there was a binding site between miR-122-5p and the 3ʹUTR of FSTL3, and the expression of FSTL3 and miR-122-5p was negatively correlated in NSCLC tissues.…”
Section: Discussionsupporting
confidence: 91%
See 1 more Smart Citation
“…27 In NSCLC, the expression of miR-221 and miR-10a were up-regulated, and their overexpression could accelerate the proliferation, migration and invasion of cancer cells. 28,29 Consistent with previous reports, 16,17 we confirmed that miR-122-5p was down-regulated in NSCLC tissues and involved in the progression of NSCLC as a tumor suppressor. In addition, we also found that there was a binding site between miR-122-5p and the 3ʹUTR of FSTL3, and the expression of FSTL3 and miR-122-5p was negatively correlated in NSCLC tissues.…”
Section: Discussionsupporting
confidence: 91%
“…15 Additionally, miR-122-5p is underexpressed in NSCLC, which can regulate the epithelialmesenchymal transition (EMT) of NSCLC cells. 16,17 This study explored the biological function of FSTL3 in NSCLC. We proved that FSTL3 expression was upregulated in NSCLC, and overexpression of FSTL3 could promote proliferation and metastasis of NSCLC, while knockdown of FSTL3 played an opposite role.…”
Section: Introductionmentioning
confidence: 99%
“…In fact, AFPGC was not necessarily hepatoid adenocarcinoma in this series, and two patients with aggressive development of liver metastasis were diagnosed morphologically as poorly differentiated adenocarcinoma and mucinous adenocarcinoma. Conversely, miR-122-5p was previously shown to function as a tumor suppressor and was reported to be downregulated in several cancer types such as hepatocellular carcinoma[ 24 ], non-small-cell lung cancer[ 25 ], gallbladder carcinoma[ 26 ], bladder cancer[ 27 ], and breast cancer[ 28 ]. In GC, the expression of miR-122-5p was reported to be lower in tumor tissue than the adjacent non-cancerous tissue.…”
Section: Discussionmentioning
confidence: 99%
“…The cells were incubated in the transwells at 37°C in 5% CO 2 for 4 hours (for migration) or 24 hours. 24 Finally, invading or migrating cells were fixed and stained with critical violet (0.5% diluted in 20% ethanol). The migration or invasion cells were harvested by glacial acetic acid and measured using a multifunctional microplate reader at 546 nm.…”
Section: Methodsmentioning
confidence: 99%